EirGenix (TPE:6589) Total Operating Expense: NT$1,037 Mil (TTM As of Dec. 2025)


TPE:6589 EirGenix Inc TPE:6589
58 GF Score
Price NT$50.70
GF Value NT$92.47
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is EirGenix Total Operating Expense?

EirGenix TPE:6589 -1.36% 58 Total Operating Expense is NT$1,037 Mil as of Dec. 2025. GuruFocus rates TPE:6589 with a GF Score™ of 58/100 and a GF Value™ of NT$92.47 (Possible Value Trap). The stock has 6 warning signs investors should review.

EirGenix's Total Operating Expense for the three months ended in Dec. 2025 was NT$395 Mil. EirGenix's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1,037 Mil.

EirGenix Total Operating Expense Related Terms

EirGenix Total Operating Expense Historical Data

* Premium members only.

The historical data trend for EirGenix's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EirGenix Total Operating Expense Chart

EirGenix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,150.68 1,087.66 1,268.72 1,084.85 1,037.21

EirGenix Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 287.93 253.40 179.55 209.74 394.52
TPE:6589
58GF Score
EirGenix Inc TPE:6589
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EirGenix Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,037 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of NT$1,037 Mil mean?
EirGenix (TPE:6589) has a Total Operating Expense of NT$1,037 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on EirGenix and its competitors.
Is EirGenix's Total Operating Expense too high?
EirGenix's current Total Operating Expense is NT$1,037 Mil. Overall, EirGenix has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EirGenix's Total Operating Expense compare to VRTX and REGN?
EirGenix's Total Operating Expense of NT$1,037 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on EirGenix and its competitors. EirGenix's current Total Operating Expense is NT$1,037 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EirGenix stock overvalued right now?
Based on GuruFocus' analysis, EirGenix (TPE:6589) is currently considered Possible Value Trap. The stock's GF Value™ is NT$92.47, compared to a current price of NT$50.70 — trading 45.2% below its estimated fair value. The current Total Operating Expense is NT$1,037 Mil. EirGenix's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For EirGenix (TPE:6589), the current Total Operating Expense is NT$1,037 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EirGenix (TPE:6589) Overvalued in 2026?

Based on GuruFocus' analysis, EirGenix stock appears to be undervalued. The current stock price of NT$50.70 is trading 45.2% below its estimated GF Value™ of NT$92.47. GuruFocus considers EirGenix to be Possible Value Trap.

Key valuation signals for TPE:6589:

  • Total Operating Expense: NT$1,037 Mil
  • GF Value™: NT$92.47 vs. price of NT$50.70 (45.2% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the TPE:6589 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EirGenix Business Description

Address No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
EirGenix Inc is engaged in the research and development of biosimilars and new drugs, as well as biopharmaceutical contract development and manufacturing services, which included cell line construction platforms, process development platforms, analytical science and protein identification. Its products include CRM197 CARRIER PROTEIN, PRODUCT PIPELINE, COVID-19 ANTIGEN RAPID TEST. The revenue is derived from biopharmaceutical contract development and manufacturing services, sales of authorization and cooperative development, and sales of goods. Geographically, it operates in Japan, Taiwan, USA and Canada, Mainland China, Hong Kong, and Macao, and Europe, Others.
58GF Score

Get the complete analysis for TPE:6589

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.70
Price
NT$92.47
GF Value